Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $90.3 million.

  • Organogenesis Holdings' Total Current Liabilities rose 1687.09% to $90.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.3 million, marking a year-over-year increase of 1687.09%. This contributed to the annual value of $77.5 million for FY2024, which is 376.6% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Total Current Liabilities is $90.3 million, which was up 1687.09% from $65.8 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Total Current Liabilities peaked at $90.3 million during Q3 2025, and registered a low of $65.1 million during Q1 2025.
  • For the 5-year period, Organogenesis Holdings' Total Current Liabilities averaged around $79.4 million, with its median value being $80.5 million (2023).
  • Per our database at Business Quant, Organogenesis Holdings' Total Current Liabilities surged by 3499.13% in 2021 and then crashed by 2319.92% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Total Current Liabilities stood at $82.7 million in 2021, then dropped by 9.29% to $75.0 million in 2022, then rose by 7.31% to $80.5 million in 2023, then dropped by 3.77% to $77.5 million in 2024, then increased by 16.58% to $90.3 million in 2025.
  • Its last three reported values are $90.3 million in Q3 2025, $65.8 million for Q2 2025, and $65.1 million during Q1 2025.